P.A.W. Capital Corp Cognition Therapeutics Inc Transaction History

P.A.W. Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$1.67 - $3.6 $58,450 - $126,000	-35,000 Reduced 25.93%	100,000 $190,000
Q2 2022 Jul 13, 2022	BUY	$1.5 - $3.45 $22,500 - $51,750	15,000 Added 12.5%	135,000 $285,000
Q1 2022 Apr 21, 2022	BUY	$2.41 - $6.9 $48,200 - $138,000	20,000 Added 20.0%	120,000 $330,000
Q4 2021 Feb 10, 2022	BUY	$5.1 - $12.98 $509,999 - $1.3 Million	100,000 New	100,000 $632,000

9.4M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $43.4M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.